Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction - a survey of the HFA and the CCP of the ESC
Event:
Heart Failure 2024
Topic:
Pharmacotherapy
Session:
Management of heart failure in real world
Iron deficiency in heart failure - prevalence, symptoms, functional capacity and health-related quality of life, and outcomes according to different definitions
Association between use of renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitors and beta-blockers and outcome in real-world heart failure and mildly reduced ejection fraction
Event:
ESC Congress 2022
Topic:
Heart Failure with Mid-Range Ejection Fraction (HFmrEF)
Session:
HFpEF and HFmrEF: what’s new in treatment?
Determinants of and association with outcomes of referral to specialty vs. primary care in patients with heart failure: data from the Swedish Heart Failure registry